OBJECTIVES/HYPOTHESIS: The cystic fibrosis transmembrane conductance regulator (CFTR) serves as a predominant Cl(-) transport conduit in airway epithelium and is inhibited by cigarette smoke in vitro and in vivo. Activation of secondary Cl(-) transport pathways through calcium-activated Cl(-) channels (CaCC) has been postulated as a mechanism to bypass defects in CFTR-mediated transport. Because it is not known whether CaCCs are also inhibited by tobacco exposure, the current study was designed to investigate the effect of cigarette smoke condensate (CSC) on CaCC transport. STUDY DESIGN: In vitro study. METHODS: Well-characterized primary murine nasal septal epithelial (MNSE) and human sinonasal epithelial (HSNE) cultures were exposed to CSC in Ussing chambers. We monitored CaCC short-circuit current through stimulation of P2Y purinergic receptors with uridine triphosphate or adenosine triphosphate and selective inhibition of the CFTR-dependent secretory pathway. Characterization of CaCC current was also accomplished in primary airway cells derived from transgenic CFTR(-/-) (knockout) murine models. RESULTS: Change in CaCC-mediated current (DeltaI(SC) representing transepithelial Ca-mediated Cl(-) secretion in muA/cm(2)) was significantly decreased in CSC-exposed wild type MNSE when compared to controls (32.8 +/- 4.6 vs. 47.5 +/- 2.3; respectively; P < .02). A similar effect was demonstrated in CFTR(-/-) MNSE cultures (33.4 +/- 2.8 vs. 38.6 +/- 2.0; P < .05>. HSNE cultures also had a significant reduction in I(SC) (16.1 +/- 0.6 vs. 22.7 +/- 0; P = .008). CONCLUSIONS: CSC affects multiple pathways fundamental to airway ion transport, including both cyclic adenosine monophosphate and calcium activated Cl(-) transport. Inhibition of Cl(-) transport may contribute to common diseases of the airways, such as chronic rhinosinusitis and chronic obstructive pulmonary disease.
OBJECTIVES/HYPOTHESIS: The cystic fibrosis transmembrane conductance regulator (CFTR) serves as a predominant Cl(-) transport conduit in airway epithelium and is inhibited by cigarette smoke in vitro and in vivo. Activation of secondary Cl(-) transport pathways through calcium-activated Cl(-) channels (CaCC) has been postulated as a mechanism to bypass defects in CFTR-mediated transport. Because it is not known whether CaCCs are also inhibited by tobacco exposure, the current study was designed to investigate the effect of cigarette smoke condensate (CSC) on CaCC transport. STUDY DESIGN: In vitro study. METHODS: Well-characterized primary murine nasal septal epithelial (MNSE) and human sinonasal epithelial (HSNE) cultures were exposed to CSC in Ussing chambers. We monitored CaCC short-circuit current through stimulation of P2Y purinergic receptors with uridine triphosphate or adenosine triphosphate and selective inhibition of the CFTR-dependent secretory pathway. Characterization of CaCC current was also accomplished in primary airway cells derived from transgenicCFTR(-/-) (knockout) murine models. RESULTS: Change in CaCC-mediated current (DeltaI(SC) representing transepithelial Ca-mediated Cl(-) secretion in muA/cm(2)) was significantly decreased in CSC-exposed wild type MNSE when compared to controls (32.8 +/- 4.6 vs. 47.5 +/- 2.3; respectively; P < .02). A similar effect was demonstrated in CFTR(-/-) MNSE cultures (33.4 +/- 2.8 vs. 38.6 +/- 2.0; P < .05>. HSNE cultures also had a significant reduction in I(SC) (16.1 +/- 0.6 vs. 22.7 +/- 0; P = .008). CONCLUSIONS:CSC affects multiple pathways fundamental to airway ion transport, including both cyclic adenosine monophosphate and calcium activated Cl(-) transport. Inhibition of Cl(-) transport may contribute to common diseases of the airways, such as chronic rhinosinusitis and chronic obstructive pulmonary disease.
Authors: M P Anderson; R J Gregory; S Thompson; D W Souza; S Paul; R C Mulligan; A E Smith; M J Welsh Journal: Science Date: 1991-07-12 Impact factor: 47.728
Authors: M Flagella; L L Clarke; M L Miller; L C Erway; R A Giannella; A Andringa; L R Gawenis; J Kramer; J J Duffy; T Doetschman; J N Lorenz; E N Yamoah; E L Cardell; G E Shull Journal: J Biol Chem Date: 1999-09-17 Impact factor: 5.157
Authors: Marcelo B Antunes; Bradford A Woodworth; Geeta Bhargave; Guoxiang Xiong; Jorge L Aguilar; Adam J Ratner; James L Kreindler; Ronald C Rubenstein; Noam A Cohen Journal: Biotechniques Date: 2007-08 Impact factor: 1.993
Authors: Noam A Cohen; Shaoyan Zhang; Dawn B Sharp; Edwin Tamashiro; Bei Chen; Eric J Sorscher; Bradford A Woodworth Journal: Laryngoscope Date: 2009-11 Impact factor: 3.325
Authors: Christopher Azbell; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth Journal: Otolaryngol Head Neck Surg Date: 2010-09 Impact factor: 3.497
Authors: Vivian Y Lin; Matthew D Fain; Patricia L Jackson; Taylor F Berryhill; Landon S Wilson; Marina Mazur; Stephen J Barnes; J Edwin Blalock; S Vamsee Raju; Steven M Rowe Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Nathan S Alexander; Neal Hatch; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth Journal: Laryngoscope Date: 2011-04-07 Impact factor: 3.325
Authors: Shaoyan Zhang; Nicholas Smith; Daniel Schuster; Christopher Azbell; Eric J Sorscher; Steven M Rowe; Bradford A Woodworth Journal: Am J Rhinol Allergy Date: 2011 Sep-Oct Impact factor: 2.467
Authors: Nithin D Adappa; Carl M Truesdale; Alan D Workman; Laurel Doghramji; Corrine Mansfield; David W Kennedy; James N Palmer; Beverly J Cowart; Noam A Cohen Journal: Int Forum Allergy Rhinol Date: 2016-06-16 Impact factor: 3.858
Authors: Do-Yeon Cho; Shaoyan Zhang; Ahmed Lazrak; Jessica W Grayson; Jaime A Peña Garcia; Daniel F Skinner; Dong Jin Lim; Calvin Mackey; Catherine Banks; Sadis Matalon; Bradford A Woodworth Journal: Int Forum Allergy Rhinol Date: 2018-08-27 Impact factor: 3.858